对N-甲基[d]oxazol-2-amine的杀虫疗效评估和机制
Pattaneeya Prangthip1, Jumreang Tummatorn2,3, Poom Adisakwattana4
1Department of Tropical Nutrition and Food Science, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.
Scientific reports
|December 21, 2023
概括
一种新型化合物N-methylbenzo[d]oxazol-2-amine (1) 是一种有前途的杀虫剂,在小鼠中减少了49%的寄生虫圆虫感染. 需要进一步的研究来探索其在牲畜和人类中治疗线虫感染的潜力.
科学领域:
- 兽医寄生虫学 兽医寄生虫学
- 药物发现 药物发现 药物发现
- 分子生物学分子生物学
背景情况:
- 寄生性圆虫 (阴茎虫) 在动物和人类的全球健康和经济负担造成了重大影响.
- 现有的甲虫药物面临着挑战,包括耐药性和低于最佳的治疗适用性.
- 迫切需要新的甲虫药物化合物来对抗广泛的感染.
研究的目的:
- 评估N-甲基[d]oxazol-2-amine (化合物1) 的体内杀虫性质.
- 评估毒性并阐明化合物1对Trichinella spiralis的作用模式.
- 探索化合物1作为一种新型抗虫药物开发的潜在候选物.
主要方法:
- 在体内测试了与Trichinella spiralis感染的小鼠的虫杀虫疗效.
- 在大鼠中评估了急性毒性,并确定了LD50.
- 使用分子对接和代谢学分析研究了作用模式.
- 分析了化合物1对T. spiralis中的纯素,金胺和脂代谢的影响.
主要成果:
- 化合物1在250mg/kg的剂量下降了T. spiralis在消化道中的丰度49%.
- 该化合物具有较低的急性毒性,LD50大于2000mg/kg.
- 分子对接表明,氨酸和谷氨酸门通道不太可能是主要目标.
- 代谢学揭示了化合物1对氨酸和胺酸代谢进行上调,同时对脂代谢进行下调.
结论:
- N-甲基[d]oxazol-2-amine (1) 在体内表现出显著的甲虫杀伤活性和低毒性.
- 化合物1代表了一种潜在的分子,用于开发新的防虫疗法.
- 建议对生物可用性,药理动力学和吸收进行进一步研究,以优化疗效.
相关概念视频
01:26Cholinergic Antagonists: Therapeutic Uses
749
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
749
01:24Cholinergic Antagonists: Pharmacokinetics
445
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
445
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
264
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
264
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
298
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
298
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
675
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
675
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K